arrow
BackJournal Details
R

Rheumatology and Therapy

IF2.9
Papers155
Citations2022
Journal Papers 142
Publication Date
Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study
delete2026-08-13
delete0
deleteOAAI
deleteRohit Aggarwal; Joachim Schessl; Zsuzsanna Bata-Csörgő; Mazen M. Dimachkie; Zoltan Griger; Sergey Moiseev; Chester V. Oddis; Elena Schiopu; Jiri Vencovský; Elisabeth Clodi; Todd Levine; Christina Charles-Schoeman
deleteShare
deleteSave
Longitudinal Instability of Minimal Disease Activity Domains in Psoriatic Arthritis with Fluctuating Response: A Trajectory Analysis of a Real-World Cohort
delete2026-07-31
delete0
deleteOAAI
deleteMauro Fatica; Fabio Massimo Perrotta; Noemi Italiano; Eneida Çela; Maria Sole Chimenti; Ennio Lubrano
deleteShare
deleteSave
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies
delete2026-07-31
delete0
deleteOAAI
deleteGerd R. Burmester; James Galloway; Karen Bevers; Jérôme Avouac; Susana Romero-Yuste; Roberto F. Caporali; Neil Betteridge; Carole Van der Donckt; Thomas P. A. Debray; Ouafia Tandjaoui Bouzid; Patrick Verschueren
deleteShare
deleteSave
Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs
delete2026-07-24
delete0
deleteOAAI
deleteTaylor T. Schwartz; Hanke Zheng; Laetitia N’Dri; Sang Hee Park; Kristofer Norris; Vardhaman A. Patel; Scott B. Robinson; Keith Wittstock; Vadim Khaychuk; Alison R. Silverstein; Jeffrey A. Sparks
deleteShare
deleteSave
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor
delete2026-07-14
delete0
deleteOAAI
deleteChristina Charles-Schoeman; Kurt Oelke; Patrick M. Zueger; Yi Peng; Gregory Markley; Richard Thielen; Siran Fang; Martin Bergman
deleteShare
deleteSave
Duration of Belimumab Therapy and Timing of Initiation as Predictors of Clinical Outcomes in Childhood-Onset Systemic Lupus Erythematosus: A Real-World Retrospective Study
delete2026-07-11
delete0
deleteOAAI
deleteBaixu Sun; Shipeng Li; Fengqiao Gao; Shuo Liu; Wei Zhao; Junmei Zhang; Xiaohua Tan; Chao Li; Caifeng Li
deleteShare
deleteSave
Comparison of Systemic Corticosteroid Therapy Practices Between Pediatric and Adult Rheumatologists: A Multicenter Survey Study
delete2026-06-25
delete0
deleteOAAI
deleteÖvgü Özenli Yağcı; Çisem Yıldız; Deniz Gezgin Yıldırım; Emre Bilgin; Sevcan A. Bakkaloğlu
deleteShare
deleteSave
Psychological Aspects of Rheumatic Diseases: Psychorheumatology in Clinical Practice
delete2026-06-23
delete0
deleteOAAI
deleteDomniki M. Karagianni; Christina G. Katsiari; Konstantinos Bonotis; Lazaros I. Sakkas
deleteShare
deleteSave
Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study)
delete2026-06-22
delete0
deleteOAAI
deleteYoshiya Tanaka; Yuzo Kodama; Shingo Nakayamada; Atsushi Masamune; Hirokazu Sato; Akiko Takahashi; Junichiro Shibata; Yusuke Takeshima; Mitsuhiro Kawano
deleteShare
deleteSave
Optical Spectral Transmission Imaging in Patients with Osteoarthritis: A Comparative Study with Joint Ultrasound and Clinical Markers
delete2026-06-18
delete0
deleteOAAI
deleteKonstantinos Triantafyllias; Stefanie Liverakos; Khalid K. Altamimi; Ann-Kathrin Druck; Svea Gauch; Ioannis Parodis; Dionysis Nikolopoulos; Christian Geber; Muthuraman Muthuraman; Andreas Schwarting
deleteShare
deleteSave
Clinically Amyopathic Dermatomyositis: Epidemiology, Clinical Presentation, Pathophysiology, Treatment, and Prognosis: A Systematic Review
delete2026-06-16
delete0
deleteOAAI
deleteJucier Gonçalves Júnior; Jamily Izabel Alves dos Santos; Samuel Katsuyuki Shinjo
deleteShare
deleteSave
Longitudinal Trajectories and Predictors of Health-Related Quality of Life in Systemic Lupus Erythematosus: A 2-Year Longitudinal Cohort Study
delete2026-06-12
delete0
deleteOAAI
deleteWan-Yun Hsu; Ching-Yi Lai; Li-Yun Tsai; I.-Chieh Chen; Jun-Peng Chen; Kai-Ting Chen; Chung-Mao Kao; Yen-Ju Chen; Kuo-Tung Tang; Wei-Ting Hung; Wen-Nan Huang; Yi-Ming Chen
deleteShare
deleteSave
Fatigue in Sjögren’s Disease - Integrating Biomedical and Psychosocial Aspects: A Narrative Review
delete2026-06-06
delete0
deleteOAAI
deleteXinyao Zhou; Jinzhou Chen; Pascal Cathebras; Martin Killian
deleteShare
deleteSave
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials
delete2026-06-02
delete0
deleteOAAI
deleteRaj Sengupta; Pedro M. Machado; Philippe Goupille; Martin Rudwaleit; Mohamed Sheesh; Khai Jing Ng; Marcus Ngantcha; Yan Yan; Hagen Russ; Gabriel Doridot; Yu Xue; Denis Poddubnyy; Xenofon Baraliakos; Victoria Navarro-Compán
deleteShare
deleteSave
Clinical and Economic Burden Among People with Knee Osteoarthritis and Obesity in the United States: A Retrospective Analysis
delete2026-05-27
delete0
deleteOAAI
deleteDavid Schapiro; Magaly Perez-Nieves; Sylvia Gonsahn-Bollie; Kendra Terrell; Ahong Huang; Wenyang Mao; Alexandra Meeks; Pedram Azimzadeh; Julia Fraseur
deleteShare
deleteSave
Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study
delete2026-05-23
delete0
deleteOAAI
deleteJanet E. Pope; Jayeshkumar Patel; Christopher D. Saffore; Siran Fang; Al Rasymas; Dalinda Liazoghli; Olga Ziouzina
deleteShare
deleteSave
Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications
delete2026-05-18
delete0
deleteOAAI
deleteKonstantinos Tsafis; Vasileios Skepastianos; Elpida Skouvaklidou; Dimitrios Deligeorgakis; Maria Boutel; Aikaterini Kontonikola; Nikolaos Papazoglou; George E. Fragoulis; Nikolaos Kougkas
deleteShare
deleteSave
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials)
delete2026-05-16
delete0
deleteOAAI
deleteRoy M. Fleischmann; Vibeke Strand; Eugen Feist; Tatiana Lisitsyna; Jeffrey A. Sparks; Evgeny Nasonov; Mikhail Samsonov; Sergey Grishin; Alina Egorova; Sofiya Kuzkina; Josef S. Smolen
deleteShare
deleteSave